We have established an erythropoietin-dependent human leuonly human leukemic cell line that is exclusively EPO depenkemia cell line, AS-E2, from a patient with acute myeloid leukedent. Because of its late erythroid cell characteristics and its mia. These cells have many characteristics of late erythroid strict EPO dependency, we think that AS-E2 is a good model progenitor cells, they are positive for CD36, Glycophorin A, and to study the effect of EPO on erythroid cell growth and signal (ASD-chE), but some of them were positive for periodic acidand they also play an integral role in leukemic cell growth. [6] [7] [8] [9] [10] [11] [12] and are useful tools for the cloning of cytokine therapy was initiated including bephenoyl Ara-c, daunorubicgenes, cytokine receptor genes, and for studying signal transine and 6MP. A complete remission was obtained in March, duction after cytokine stimulation and the role of cytokines in but the leukemia relapsed in May 1993. The leukemia became hematopoiesis. Among many cytokines, erythropoietin (EPO) resistant to chemotherapy and the patient died in September is an important cytokine which regulates commitment, 1993. growth, differentiation and/or survival of erythroid lineage cells through its interaction with a specific receptor, especially at the late stage of erythroid progenitors like BFU-E, CFU-E or Cell culture and cell count more mature erythroid cells. 13, 14 Although some EPO-responsive human leukemia cell lines have been reported, most of AS-E2 cells were cultured in Iscove's modified Dulbecco's them also respond to other cytokines, such as granulocytemedium (IMDM) supplemented with 20% heat inactivated macrophage colony-stimulating factor (GM-CSF) or interleufetal bovine serum (FBS) in the presence of 2 U/ml of EPO kin-3 (IL-3). 8, 9 and antibiotics. The data were generated after 12 months of In this paper, we report the establishment and the charactercontinuous culture. To examine EPO dependency, AS-E2 cells istics of a new human leukemia cell line, AS-E2, which shows were washed twice with IMDM and resuspended in IMDM some features of late erythroid lineage cells and exclusive EPO containing 20% FBS without EPO. AS-E2 cells were also culdependency in its growth. As far as we know, AS-E2 is the tured in the presence of both EPO and rabbit anti-human EPO antibody in order to inhibit the EPO effect in the culture medium.
Introduction 21.8%, WBC 7800/l, platelets 8.1 × 10 4 /l. Immature blasts consisted of 12% of the peripheral blood leukocytes. The Leukemic cell lines have been useful models for the study of bone marrow was hypercellular and 96% of the bone marrow hematopoietic cell growth or differentiation and have promononuclear cells were immature blasts. The blasts stained vided information about leukemogenic events and normal negatively for myeloperoxidase (MPO), alpha-naphthyl butyrhematopoiesis. 1 Cytokines are essential for the growth, comate esterase (NBE), naphthol AS-D chloroacetate esterase mitment and differentiation of normal hematopoietic cells, 2, 3 (ASD-chE), but some of them were positive for periodic acidand they also play an integral role in leukemic cell growth. 3 Schiff (PAS) in a dotted pattern. The surface marker analysis Most leukemic cells remain dependent on growth factors for of these immature cells revealed positivity of CD13, 33.7%; in vitro growth. However, autocrine stimulation of cell growth CD11b, 31.8%; CD33, 47.7%; lymphoid markers were negahas been reported, 4 with some leukemia cells expressing both tive (CD3, 1.8%; CD2, 1.6%; CD19, 18.3%; CD10, 1.1%; cytokines and their receptors. 5 CD25, 1.0%). A diagnosis of acute myeloid leukemia (AML Cytokine-dependent leukemia cell lines have been estab-M6 variant 15 ) was made and intensive combination chemolished [6] [7] [8] [9] [10] [11] [12] and are useful tools for the cloning of cytokine therapy was initiated including bephenoyl Ara-c, daunorubicgenes, cytokine receptor genes, and for studying signal transine and 6MP. A complete remission was obtained in March, duction after cytokine stimulation and the role of cytokines in but the leukemia relapsed in May 1993. The leukemia became hematopoiesis. Among many cytokines, erythropoietin (EPO) resistant to chemotherapy and the patient died in September is an important cytokine which regulates commitment, 1993. growth, differentiation and/or survival of erythroid lineage cells through its interaction with a specific receptor, especially at the late stage of erythroid progenitors like BFU-E, CFU-E or Cell culture and cell count more mature erythroid cells. 13, 14 Although some EPO-responsive human leukemia cell lines have been reported, most of AS-E2 cells were cultured in Iscove's modified Dulbecco's them also respond to other cytokines, such as granulocytemedium (IMDM) supplemented with 20% heat inactivated macrophage colony-stimulating factor (GM-CSF) or interleufetal bovine serum (FBS) in the presence of 2 U/ml of EPO kin-3 (IL-3). 8, 9 and antibiotics. The data were generated after 12 months of In this paper, we report the establishment and the charactercontinuous culture. To examine EPO dependency, AS-E2 cells istics of a new human leukemia cell line, AS-E2, which shows were washed twice with IMDM and resuspended in IMDM some features of late erythroid lineage cells and exclusive EPO containing 20% FBS without EPO. AS-E2 cells were also culdependency in its growth. As far as we know, AS-E2 is the tured in the presence of both EPO and rabbit anti-human EPO antibody in order to inhibit the EPO effect in the culture medium.
10 ng/ml), IL-2 (1 or 10 ng/ml), IL-3 (10 or 100 ng/ml), IL-4 (1 a fluorescein isothiocyanate (FITC)-conjugated F(ab′) 2 fragment of goat anti-mouse (Tagoimmunologicals, Camarillo, or 10 ng/ml), IL-6 (1 or 10 ng/ml), IL-7 (1 or 10 ng/ml), IL-8 (100 or 1000 ng/ml), IL-11 (1 or 10 ng/ml), GM-CSF (1 or CA, USA). After washing, cells were subjected to the immunophenotypic analysis using the flow cytometer. 10 ng/ml), transforming growth factor ␤ (TGF-␤) (10 or 100 ng/ml), oncostatin M (10 or 100 ng/ml), leukemia inhibitory factor (LIF) (1 or 10 ng/ml), stem cell factor (SCF) (1 or 10 ng/ml) and basic fibroblast growth factor (bFGF) (1 or Cytogenetic analysis 10 ng/ml) were purchased from Boehringer Mannheim (Mannheim, Germany). Erythroid differentiation factor (EDF)
Karyotypes were analyzed with a G banding technique. Karyotypes were described according to the guidelines set out in (1 or 10 ng/ml) was purchased from Austral Biologicals (San Ramon, CA, USA). Hepatocyte growth factor (HGF) (50 or International System for Human Cytogenetic Nomenclature (ISCN).
19 500 ng/ml) was purchased from R&D Systems (Minneapolis, MN, USA) and epidermal growth factor (EGF) (100 or 1000 ng/ml) was from Wakunaga Pharmaceutical (Hiroshima, Japan). Granulocyte colony-stimulating factor (G-CSF) (10 or Detection of EBV and mycoplasma 100 U/ml), EPO and anti-EPO antibody (rabbit, anti-human EPO) were obtained from Chugai Pharmaceutical (Tokyo, The cell line was determined to be free of mycoplasma contamination by using an enzyme-linked immunosorbent assay Japan). All cytokines were the recombinant variant except for IL-2 which was from natural sources. Cell viability and growth (ELIZA) kit (Boehringer Mannheim Biochemica, Tokyo, Japan).
Testing for Epstein-Barr virus infection was performed by PCR were calculated with trypan blue dye exclusion or with MTS assay 16 using CellTiter 96TM AQueous Non-Radioactive Cell analysis as described previously.
20
Proliferation Assay kit (Promega, Madison, WI, USA).
Northern blot analysis for GATA-1, GATA-2, ␥-globin, and carbonic anhydrase I gene expression Morphological and cytochemical analysis Cells were fixed on poly-L-lysine coated glass slides which Total cellular RNA was extracted from AS-E2, K562 and HL-60 cells (kindly provided by Dr David Golde, Sloan Kettering were stained with May-Grü nwald Giemsa (MGG), MPO, NBE, ASD chE and PAS using standard methods. HemoglobinCancer Center Institute, New York) using the acid guanidium phenol chloroform method. Briefly, cells were lysed in the ized cells were detected by benzidine test. 17 disrupting buffer containing 4 M guanidium thiocyanate then mixed with 0.2 M sodium acetate, phenol and chloroform. After centrifugation, total RNA was precipitated from the DNA fingerprinting aqueous phase by the addition of isopropanol. RNA pellets were washed with 70% ethanol, dried and dissolved into the DNAs were extracted from the primary leukemia cells and from the resulting cell line and analyzed using a multilocus appropriate volume of water. These samples were kept at −80°C until use. Northern blot analysis was performed as preprobe, designated 5′-gtggtggtggtggtg-3′ ((gtg) 5 ), as described in detail previously. 18 Twenty micrograms DNA were cut to viously described 21 with 32 P-labeled GATA-1, GATA-2, ␥-globin and carbonic anhydrase I cDNAs as probes. GATA-1 completion with 100 U HinfI (Nippon Gene, Japan). DNA was separated by electrophoresis in a 1% agarose gel and Southern probe was generously provided by Dr T Yamamoto (Tsukuba University, Japan); a 290-bp human GATA-2 cDNA and a blotted onto Hybond N (Amersham, Buckinghamshire, UK). The membrane was hybridized with 32 P-labeled (gtg) 5 probe 319-bp carbonic anhydrase I cDNA was generated by PCR; 22, 23 l-labeled EPO were performed as previously described. ) were PBS again. Cells were further incubated for 30 min at 4°C with incubated with or without 10 U/ml of EPO for the indicated with a moderate nuclear:cytoplasmic ratio. There are a few nucleoli in the nucleus. The cytoplasm is moderate to strongly time at 37°C. AS-E2 cells were disrupted on ice in 0.5 ml of cold lysis buffer (150 mM NaCl, 20 mM Tris-HCl pH 7.5, 1% basophilic and contains several vacuoles. These features resemble the patient's original leukemic blasts, and the baso-NP-40, 10% glycerol, 1 mM PMSF (phenylmethylsulfonyl fluoride), 0.1 mg/ml leupeptin, 5 mM pepstatin A, 1 mM EDTA philic cytoplasm with a round nucleus also resembles the features of immature erythroblasts. No Auer rods or granules and 2 mM sodium orthovanadate). After centrifugation, cell extracts were mixed with 20 ml of protein G/protein A agarose were seen in the cytoplasm and the cells stained negative for MPO, NBE and ASD-chE. A low percentage of these cells (Oncogene Science) and incubated for a further 4 h at 4°C with rotation. After centrifugation, the supernatant was incushowed positive for PAS staining in a dotted pattern, similar to the patient's original leukemic blasts, and approximately bated with 3 ml of JAK2 antiserum (Upstate Biotechnology, Lake Placid, NY, USA), 1.5 mg of affinity purified antibody 30% of the cells were benzidine positive. against the EPO-R (Upstate Biotechnology), 1.5 mg of monoclonal antibody against phosphotyrosine residues (25.2G4; Wako Pure Chemical Industries, Osaka, Japan), or 1.5 mg of Cell surface marker analysis negative control antibody (DAKO, Glostrup, Denmark). After 2 h of incubation at 4°C, 20 ml of protein G/protein A agarose
The phenotypic characterization of the AS-E2 cell line is shown in Table 2 . Compared with the original leukemic cells, was added, and the samples were further incubated for 2 h with rotation. Immunocomplexes with protein G/protein A established AS-E2 cells lost expression of myeloid surface markers; CD33, CD13 and CD11b positivity became very agarose were washed five times with lysis buffer, and were eluted by boiling in 25 ml of SDS-sample buffer for 5 min.
low. Glycophorin A (GPA) which is an erythroid cell marker 28 was positive and 98.9% of cells were positive for plateletSamples were separated by SDS containing 10% polyacrylamide gel electrophoresis (PAGE) and transferred to Immobilon-P associated marker, CD36 (gpIV/IIIb), which is known to be expressed in platelets and erythroid cells. 29 The transferrin membranes (Millipore, Bedford, MA, USA). These membranes were blocked and incubated for 2 h at room temperature with receptor, CD71, was positive for 99.1% of cells. CD41, a megakaryocytic lineage marker, was negative. CD34 and the anti-phosphotyrosine antibody (25.2G4). After washing and incubation with biotin-labeled anti-mouse immunoglobin HLA-DR, two markers of primitive hematopoietic cell, 30 were negative on AS-E2 cells. (Amersham) and horseradish peroxidase-conjugated streptavidin (Amersham), bands were visualized using peroxidase staining. The peroxidase activity was detected by 3, 3′-diamino-benzidine.
Cytogenetic analysis
Cytogenetic study of the bone marrow specimen obtained at the time of admission showed 46XY. AS-E2 had a near-tetraResults ploid karyotype with a modal chromosome number of 67-82. The karyotype of AS-E2 cells was determined as follows: 67-Establishment of AS-E2 cell line 82, XXYY, del(1)(p32p36), −2X2, del(3)(p21), del(3)(q21), −4, der(4)t(1;4)(q21;p16)X2, −5, add(8)(p23), add(8)(q24)X2, Bone marrow cells were aspirated from the patient's sternum after his leukemia relapsed, after obtaining informed consent. add(9)(q34), +del(9) (q11q22), −10X2, add(10)(p14), add(11)(q23), i(11)(q10), −13X2, +14, −15X2, add(15)(p12), Mononuclear cells were separated from this bone marrow sample using Ficoll-Hypaque centrifugation, and the phago-−16X2, −17, −18, −19X2, −22X2, +markers [cp20] (Figure 3 ). cytic cells were removed using an iron beads magnetic method as previously described.
27 Non-phagocytic mononuclear cells were cultured in 0.88% of methylcellulose in Cytokine responsiveness of AS-E2 cells IMDM containing 20% of heat inactivated FBS, 0.5% of BSA (bovine serum albumin) and 2 U/ml of EPO. A few cell clusBecause EPO was always added to the culture medium during the establishment of the AS-E2 cell line, we thought that the ters began to grow from the initial culture after 4 weeks and reached colony size within a few weeks. Several colonies proliferation of AS-E2 cells might be dependent on EPO. To clarify this possibility, we examined the cytokine dependency were transferred from methylcellulose culture to liquid culture (in IMDM with 20% of FBS and 2 U/ml of EPO) in 24-well of the growth of these cells. AS-E2 cells showed EPO-dependent proliferation ( Figure 4a) ; without EPO in the culture culture plates. Three clones, including this cell line, continued to grow in the liquid culture and we concentrated on one of medium, these cells could not survive or proliferate. The addition of anti-EPO antibody into the culture medium had these clones which we named AS-E2. AS-E2 cells have continued to grow in liquid culture for more than 1 year using the same effect as EPO depletion on the proliferation or survival of AS-E2 cells (Figure 4b ), clearly showing their EPO the same culture conditions. Technical aspects of cell culturing are listed in Table 1 . DNA fingerprinting proved unequivodependency.
We examined extensively the effect of other cytokines on cally that AS-E2 was indeed derived from the patient described ( Figure 1 ). The cultures are free from Epstein-Barr the growth of AS-E2 cells. MTS assay was performed with 20 human cytokines at high and low concentrations ( Figure 5 ). virus and mycoplasma (data not shown).
AS-E2 did not respond to any of these cytokines including GM-CSF, IL-3, stem cell factor (SCF), basic fibroblast growth factor (bFGF) or IL-6. Neither thrombopoietin (TPO) 31 nor
Morphological and cytochemical analysis of AS-E2 macrophage colony-stimulating factor (M-CSF) promoted the growth of AS-E2 cells (data not shown). Although some of The morphological appearance of AS-E2 cells resembles that of immature blast cells (Figure 2 ). The cells are about 30 m these cytokines are reported to support the growth of immature hematopoietic cells or erythroid lineage cells specifically, in size, the nucleus is round, and the nuclear texture is fine GATA-1, GATA-2, ␥-globin, and carbonic anhydrase I gene expression logical and cytochemical features, cell surface marker (1)(p32p36), −2 X 2, del(3)(p21), del(3)(q21), −4, der(4)t(1;4)(q21;p16) X 2, −5 add(8)(p23), add(8)(q24) X 2, add(9)(q34), +del(9) (q11q22), −10 X 2, add(10)(p14), add(11)(q23), i(11)(q10), −13 X 2, +14, −15 X 2, add(15)(p12), −16 X 2, −17, −18, −19 X 2, −22 X 2, +markers.
expression and cytokine dependency resemble those of erythroid lineage cells. To demonstrate further the erythroid phenotype of these cells, we next analyzed the expression of ␥-globin and GATA-1 gene. The former is expressed only in erythroid and the latter in erythroid, megakaryocytic and mast cell lineage in hematopoietic systems. Northern blot analysis revealed that ␥-globin and GATA-1 genes were expressed in AS-E2 cells, at a greater level than in K562 cells, which have already been shown to have erythroid characteristics. 32 AS-E2 also expressed carbonic anhydrase I gene which has been shown to be expressed in erythroid lineage, but not in K562 cells. 33 HL60 cells did not express GATA-1 (as previously reported). 32 The GATA-2 gene was expressed in AS-E2, K562, and HL60 cells ( Figure 6 ).
Expression of EPO receptors on AS-E2 cells
Because AS-E2 showed a strict dependency on EPO for its growth, we examined their EPO receptor (EPO-R) expression using 125 I-labeled EPO. The data from a scatchard analysis are shown in Figure 7 ; this cell line has 9077 EPO binding sites EPO induces many cellular responses through the EPO-R, and some of its signal transduction pathways are thought to involve tyrosine phosphorylation of cellular proteins. 34, 35 To evaluate the tyrosine phosphorylation of AS-E2 cellular proteins in response to EPO stimulation, we analyzed the tyrosine phosphorylation pattern of AS-E2 cells using an anti-phospho-130 kDa, that are not seen using unstimulated cell lysates (Figure 8 ). This demonstrates the existence of cellular proteins tyrosine antibody. Five minutes after EPO stimulation, whole cell lysate of AS-E2 revealed new tyrosine phosphorylation whose tyrosine residues are phosphorylated quickly after EPO stimulation. bands of approximately 58 kDa, 72 kDa, 120 kDa and lation. So, we next examined whether the JAK2 and EPO-R proteins are tyrosine phosphorylated after EPO stimulation of AS-E2 cells. Those proteins were immunoprecipitated before and after EPO stimulation, using an anti-JAK2 or an anti-EPO-R antibody, and analyzed using an antiphosphotyrosine antibody. As shown in Figure 7 , both JAK2 and EPO-R are tyrosine phosphorylated after 5 min of EPO stimulation. Tyrosine phosphorylated EPO-R was detected at ෂ72 kDa and tyrosine phosphorylated JAK2 was detected at ෂ130 kDa, almost the same size as reported previously. 36, 37 These bands were not detectable before EPO stimulation; the same size bands were detected in the analysis of tyrosine phosphorylated proteins using total cellular lysate ( Figure 9 ). These results clearly show that EPO stimulation induces tyrosine phosphorylation of JAK2 and the EPO-R in AS-E2 cells.
Discussion
In this study, we report the establishment of a novel human leukemia cell line, AS-E2, from a patient with acute myeloid Northern blot analysis of GATA-1, GATA-2, ␥-globin and carbonic anhydrase I gene expression. Total RNA prepared from ASleukemia whose leukemia blasts showed some erythroid cell P-labeled differentiated erythroid leukemia. 38 The characteristics of leu-GATA-1, GATA-2, ␥-globin and carbonic anhydrase I probes were kemia blasts of the present case are similar to those described hybridized and washed in high stringency condition. Signals were in our previous case. Recently, another group has reported the visualized using autoradiography.
existence of early erythroid cell leukemia which is different to the M6 subtype described in the FAB classification. 15 These cases may be similar enough to justify a new category or subTyrosine phosphorylation of EPO-R and JAK2 after EPO stimulation type of acute myeloid leukemia.
From the morphological, cytochemical immunophenotypic and gene expression analysis, AS-E2 cells display many There have been some reports that one of the non-receptor type tyrosine kinases, JAK2, is involved in signal transduction important features of erythroblasts. These include hemoglobin and PAS positivity, the presence of GPA and CD36 on the from the EPO-R. 36, 37 Tyrosine residues in JAK2 itself, and in the EPO-R, are reported to be phosphorylated after EPO stimucell surface, and CA-I, GATA-1 expression, 43 Because AS-E2 cells do not have megakaryocytic cell surface markers, like CD41, and do not respond to TPO, they may provide new insights into the lineage commitment of erythroid and megakaryocytic cells.
The growth of AS-E2 cells is specifically dependent on EPO. Other cytokines including IL-1, -3, -6, SCF, which can promote primitive hematopoietic cell growth cannot support the growth of AS-E2 cells. EDF, which was reported to have a stimulatory effect on erythropoiesis, 44 did not promote the growth of this cell line, although we did not examine the growth promoting effect of EDF in the presence of EPO. IL-11, bFGF and HGF, which are thought to increase erythroid progenitor 45 or to enhance the proliferation of early hematopoietic cells, 46, 47 did not show any promotion of cell growth, either. This exclusive EPO dependency resembles the cytokine responsiveness of late erythroid lineage cells.
14 Factor-dependent human leukemia cell lines have been reported and several of them respond to EPO. However, most EPO-responsive cell lines also respond to other cytokines like GM-CSF or IL3. [7] [8] [9] [10] For example, the cytokine-dependent TF-1 cell line, grows in liquid culture in the presence of EPO, yet both GM-CSF and IL-3 can also support the growth of this cell line. As far as we know, only the UT-7/Epo cell line has EPO dependency without responsiveness to GM-CSF or IL-3 (unlike on the growth of human hematopoietic cells. Many reports have been published about the signal transduction events mediated by the EPO-R, and the role of tyrosine phosphorylation of cellular proteins, including the EPO-R and the JAK2 tyrosine kinase. 35, 37 After EPO stimulation, AS-E2 cells showed rapid tyrosine phosphorylation of several cellular proteins, and immunoprecipitation studies clearly demonstrated that EPO-R and JAK2 are among the phosphorylated proteins in AS-E2 cells. Tyrosine phosphorylation of both proteins have previously been reported to play an integral role in EPO signal transduction. 36, 37 This was shown using genetically engineered EPO-R over-expressing cells, and we confirmed these phosphorylation events using our EPOdependent human leukemia cell line. We did not examine the using AS-E2 cells, which should provide a good model to study all characteristics of late stage erythroid cells. expression and EPO-dependent cell growth are also important characteristics of erythroid lineage cells. 13, 30 These features Note resemble some characteristics of BFU-E or CFU-E, which are committed erythroid lineage cells in the normal erythroid cell The cell line AS-E2 can be provided to outside investigators by written request to K Kuriyama. differentiation process. 40 Thus far, this cell line does not have
